Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
INO-6160 by Inovio Pharmaceuticals for Human Immunodeficiency Virus (HIV) Infections (AIDS): Likelihood of Approval
INO-6160 is under clinical development by Inovio Pharmaceuticals and currently in Phase I for Human Immunodeficiency Virus (HIV) Infections (AIDS)....
VRC-01 by Inovio Pharmaceuticals for Human Immunodeficiency Virus (HIV) Infections (AIDS): Likelihood of Approval
VRC-01 is under clinical development by Inovio Pharmaceuticals and currently in Phase II for Human Immunodeficiency Virus (HIV) Infections (AIDS)....
Zenuzolac by Inovio Pharmaceuticals for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval
Zenuzolac is under clinical development by Inovio Pharmaceuticals and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Pneumonia. According...
Zenuzolac by Inovio Pharmaceuticals for Diabetic Nephropathy: Likelihood of Approval
Zenuzolac is under clinical development by Inovio Pharmaceuticals and currently in Phase I for Diabetic Nephropathy. According to GlobalData, Phase...
Zenuzolac by Inovio Pharmaceuticals for Inflammation: Likelihood of Approval
Zenuzolac is under clinical development by Inovio Pharmaceuticals and currently in Phase I for Inflammation. According to GlobalData, Phase I...
INO-5401 by Inovio Pharmaceuticals for Glioblastoma Multiforme (GBM): Likelihood of Approval
INO-5401 is under clinical development by Inovio Pharmaceuticals and currently in Phase II for Glioblastoma Multiforme (GBM). According to GlobalData,...
(Bizalimogene ralaplasmid + mavilimogene ralaplasmid) by Inovio Pharmaceuticals for Anal Dysplasia: Likelihood of Approval
(Bizalimogene ralaplasmid + mavilimogene ralaplasmid) is under clinical development by Inovio Pharmaceuticals and currently in Phase II for Anal Dysplasia....